Receive consulting resources in your inbox

NMS Capital: Investment Strategy, Funds, Portfolio Companies, and Firm Profile

1. What Is NMS Capital?

NMS Capital is a private equity investment firm founded in 2010 by Martin E. Chavez and Kevin M. Jordan. Headquartered in New York, the firm developed from the spin-out of a group of investments from Goldman Sachs’ Merchant Banking Division. Its current investment focus centers on business and industrial services and healthcare services. Historically, the organization also used the name New MainStream Capital.

NMS pursues growth-oriented investments in established companies, generally seeking majority ownership while working alongside management teams. Its disclosed platform mandate covers the United States and Canada. The emphasis is on profitable businesses with opportunities for organic expansion and acquisition-driven growth.

For this directory, NMS fits the direct private equity and buyouts segment, more specifically control buyouts, lower-middle-market investing, and sector-focused private equity. Its geography group is North America. These are editorial classifications of its investment model. Inclusion in the Umbrex Top 1000 Global Private Equity Firms research collection is not a performance ranking.

2. NMS Capital at a Glance

Firm name
NMS Capital, historically also called New MainStream Capital.
Firm type
Private equity investment firm.
Founded
2010.
Founders
Martin E. Chavez and Kevin M. Jordan, both identified as co-founders and managing partners.
Headquarters
New York City; the firm also maintains a Dallas office.
Parent organization
No current corporate parent verified. Goldman Sachs’ Merchant Banking Division was the source of the founding spin-out, not an established current parent.
Main investment markets
United States and Canada, based on the firm’s current platform-company mandate.
Geography group
North America.
Directory segments
Direct private equity and buyouts; control buyouts; lower-middle-market and sector-focused private equity.
Principal strategies
Growth-oriented majority investments and acquisition-based platform development.
Ownership preference
Majority positions, generally 51% to 90%.
Typical company profile
Profitable, growing companies with initial EBITDA of US$5 million to US$25 million.
Disclosed equity investment range
US$25 million to US$100 million in the current firm overview, with potential additional capacity through limited-partner co-investments.
Sector focus
Business and industrial services; healthcare services.
Important recent funds
NMS Fund IV and NMS Fund V. Fund V’s final-close amount has not been verified.
Current status
Operating, with investment and organizational announcements published in 2026.
Official website
NMS Capital Official Website

The organizational entries reflect the firm’s current identification and disclosed history. Investment criteria are guidelines, not evidence that every transaction uses the same ownership percentage, equity amount, or financing structure.

3. Who Founded NMS Capital, and How Is the Firm Organized?

Martin E. Chavez and Kevin M. Jordan founded NMS in 2010 through a spin-out of investments from Goldman Sachs’ Merchant Banking Division. The founders remain identified by NMS as managing partners. Chavez’s published background includes service as a managing director in Goldman Sachs’ Merchant Banking Division, where he helped invest in and oversee the portfolio businesses associated with the spin-out.

The founding business was established in the United States. An exact founding city has not been independently verified for this profile. New York is the verified headquarters, and historical firm announcements also identify a New York and Dallas operating presence. The Goldman Sachs connection explains NMS’s origins; it should not be interpreted as proof of present Goldman Sachs ownership. Current management-company ownership percentages and a current corporate parent have not been verified.

The current investment organization is divided principally around its two service-sector areas. NMS identifies Luis A. Gonzalez as senior partner and head of healthcare and Daniel Schwartz as partner and head of business services. The investment organization is supported by an internal Portfolio Optimization Group and an Operating Executive Council of industry executives. These resources have different functions: the former supplies dedicated portfolio support, while the latter contributes industry experience, investment-theme development, and operating involvement.

4. What Is the History of NMS Capital?

NMS’s development is best understood as the evolution of a services-focused investment organization from an acquired founding portfolio into successive private equity funds. Its historical milestones also show a narrower present-day sector emphasis than the broader business, healthcare, and consumer remit described in early fundraising materials.

  1. 2010: Formation through a Goldman Sachs spin-out. Chavez and Jordan established the firm around a group of investments originating in Goldman Sachs’ Merchant Banking Division. The first NMS fund accompanied this initial development. The firm’s founding date should therefore be distinguished from the incorporation dates of later funds.
  2. 2014 and 2015: Fund II and a new investment cycle. NMS Fund II completed its final close in December 2014, with US$252 million of committed capital disclosed in the February 25, 2015 announcement. Its first investment was the 2014 recapitalization of IT staffing company ettain group.
  3. 2017 through 2019: Expansion of healthcare platforms and Fund III. NMS formed CORDENTAL Group in 2017 with dental-industry executives. Its February 2019 Fund III announcement reported US$450 million of commitments and identified U.S. Foot & Ankle Specialists among the fund’s initial platforms.
  4. 2020 through 2025: Fund IV and portfolio realizations. The 2020-vintage Fund IV was reported at US$570 million in fund size in a March 31, 2025 fund review. Capstone Mechanical became its eleventh and final platform investment in May 2025. During 2024 and 2025, NMS also completed exits from DirectMed Imaging, Flourish Research, DCM Services, and U.S. Urology Partners.
  5. 2026: Organizational development and new medical-equipment services exposure. NMS established a dedicated business-development leadership position in June, appointing William Gonzalez. In September, it announced Asurgence Medical, bringing ENDOCORP and Medical Optics together under a surgical-equipment maintenance and repair platform.

5. What Investment Strategies Does NMS Capital Pursue?

NMS’s principal model combines majority ownership with a growth agenda. The firm describes a preference for ownership positions of 51% to 90%, while leaving day-to-day management with portfolio-company executives. Its strategic involvement is intended to support expansion rather than replace the operating organization. This makes “growth-oriented control buyouts” a more accurate directory description than minority growth equity or early-stage venture capital.

Acquisition-based growth is a recurring part of that model. NMS can back an existing company as a platform, support additional acquisitions, and build services, geographic coverage, or technical capabilities around it. Capstone Mechanical illustrates the recapitalization of an established service provider. Asurgence Medical illustrates the creation of a platform combining complementary businesses, including a business purchased from an existing corporate owner.

Organic development also matters. NMS’s accounts of investments such as DirectMed and Flourish describe investments in capabilities, infrastructure, and technology alongside acquisitions. These examples support an interpretation of the firm as a business-building investor, but they do not establish that every holding follows an identical operating plan.

The firm’s investment principles explicitly favor restraint in borrowing and emphasize growth, people, and strategic decisions over financial engineering. That is a statement of approach, not proof that all investments are debt-free or that leverage has remained unchanged throughout each holding period.

6. What Funds Does NMS Capital Manage?

NMS’s publicly identifiable fund structure includes successive private equity limited partnerships rather than a single permanent-capital holding company. Fund-level capital should be kept separate from manager-level assets under management, portfolio-company enterprise values, and individual equity investment amounts. Its Fund II disclosure identifies institutional investors, family offices, and public pension funds among the fund’s investors.

  • NMS Fund I: Associated with the firm’s 2010 formation and initial portfolio. It is important to the firm’s origins, but this profile does not present an independently reconciled current measurement for that vehicle.
  • NMS Fund II: US$252 million of committed capital. The final close occurred in December 2014 and was subsequently announced in February 2015.
  • NMS Fund III: US$450 million of commitments at final close, disclosed in the announcement dated February 5, 2019. The fund had initially targeted US$350 million. These are fundraising measures, not portfolio valuations.
  • NMS Fund IV: A 2020-vintage fund with a reported fund size of US$570 million in the March 31, 2025 review. Capstone Mechanical was identified as its final new platform investment in May 2025. Completion of new platform investing does not mean that the fund had exited its holdings.
  • NMS Fund V: The latest numbered fund verified for this profile. Its April 27, 2026 amended offering notice reported approximately US$518.9 million cumulatively sold against a US$750 million total offering amount. These figures concern the named limited partnership and are not a verified final-close total across any related vehicles.

NMS also describes the ability to invest additional capital through limited-partner co-investments. A final-close announcement for Fund V, a named continuation vehicle, or a separate evergreen strategy has not been verified here. The absence of such verification should not be read as proof that no additional vehicle exists.

7. What Types of Companies Does NMS Capital Invest In?

The firm’s current overview describes profitable, growing companies with actionable opportunities for organic expansion or acquisitions. Its disclosed initial-company EBITDA range is US$5 million to US$25 million. The equity investment range in that overview is US$25 million to US$100 million, with the potential to commit more through limited-partner co-investments. Those measures describe different things: EBITDA concerns operating earnings, while the equity range concerns NMS’s investment capacity.

These criteria support a lower-middle-market classification, although a platform may become substantially larger during ownership. NMS’s portfolio examples include specialized commercial service providers, outsourced healthcare-related businesses, physician-practice platforms, and equipment-service companies. Its disclosed model is therefore not limited to one revenue model or one type of customer.

Founder and management recapitalizations are particularly visible in the transaction record. Capstone involved a partnership with company management. Anne Arundel Dermatology was established with practice owners, while the founding of CORDENTAL involved an executive partnership to develop a dental-support business. These examples demonstrate several routes to platform creation rather than a universal requirement that a company already have an institutional owner.

Analytically, the common thread is a business with an established operating foundation and identifiable development needs. The evidence does not establish a uniform revenue threshold, minimum enterprise value, or mandatory public-to-private transaction strategy. Nor should the examples be treated as a complete list of situations NMS would consider.

8. Which Industries Does NMS Capital Focus On?

NMS organizes its investment focus around business and industrial services and healthcare services. The underlying portfolio is more specific than those broad labels: it includes facility maintenance, environmental services, infrastructure inspection, IT consulting, medical communications, equipment lifecycle management, and specialty healthcare staffing. These are different service businesses, not interchangeable examples of one industry.

  • Facility services: Capstone Mechanical provides commercial HVAC and refrigeration maintenance, repair, and replacement services. Its activity is substantively relevant to facilities management and maintenance, rather than HVAC equipment manufacturing.
  • Dental practice support: CORDENTAL represents NMS’s exposure to dental service organizations, providing business support to affiliated dental practices. The support organization and the clinical practices should not automatically be treated as the same legal entity.
  • Specialty staffing: Pediatric Developmental Services supplies pediatric therapy and special-education personnel to school districts. This creates a relevant connection to staffing services, with a specialized healthcare and education delivery context.

Other important business models include healthcare-adjacent outsourced services and the maintenance of specialized equipment. Health & Wellness Partners supplies medical communications, while Surplus Solutions manages laboratory equipment through procurement, resale, and related services. Asurgence adds surgical-equipment repair exposure. These examples explain the services orientation without implying that NMS invests in every healthcare or industrial subsector.

9. Where Does NMS Capital Invest?

NMS is headquartered in New York City and also maintains a Dallas office. These locations identify the firm’s operating presence, not the full geographic extent of its investments. Its current overview states that it focuses on platform companies headquartered in the United States and Canada, supporting a North America geography classification.

The United States remains central to the documented portfolio and historical strategy. Earlier fund announcements described a U.S.-headquartered company focus. The current inclusion of Canada in the platform mandate should be understood as a geographic investment criterion, not proof of a particular Canadian holding or a verified allocation of capital between the two countries.

Portfolio-company operations can extend beyond the geography used to source platforms. For example, NMS’s account of its DirectMed investment describes international expansion during ownership. That is evidence of cross-border development at a portfolio company, not evidence that NMS itself operates a separate global buyout fund or has an unrestricted worldwide platform mandate.

The practical distinction is between where NMS is based, where it seeks platform-company headquarters, and where those businesses may serve customers or expand. Treating all three as the same geographic measure would obscure the firm’s actual investment model.

10. How Does NMS Capital Seek to Create Value?

NMS identifies several distinct operating resources: its Portfolio Optimization Group, industry operating executives, talent and human-capital support, strategic growth initiatives, acquisition support, and information systems. The firm describes these resources as working with portfolio-company management rather than taking over routine management responsibilities.

The Portfolio Optimization Group is an internal capability. NMS’s published biography for executive vice president Kevin Connelly describes work involving management coaching, identifying business opportunities, adding resources, and implementing priority initiatives. His background includes commercial, M&A, and operational improvement work at McKinsey. This supports the existence of a dedicated operating-support function, not a claim that every company receives the same program.

The Operating Executive Council supplies a different form of support. Bob Elfanbaum’s July 2024 appointment was associated with prospective IT-services investments, including digital transformation and managed service providers. The announcement describes industry executives contributing experience and networks to investment development and business growth. It does not establish portfolio-wide deployment of a particular technology or AI initiative.

Documented investment accounts provide more concrete examples. DirectMed’s development included repair capabilities, infrastructure investment, and international expansion. Flourish’s development included centralized infrastructure and technology alongside a buy-and-build strategy. These are company-specific descriptions of the approach, not independently demonstrated benefits at every holding.

The evidence supports capabilities in management development, data, business expansion, and acquisitions. It does not justify assuming an identical pricing, procurement, integration, or AI program across the portfolio.

11. What Types of Business Situations May Fit NMS Capital?

The following situations appear consistent with NMS’s documented strategy. They are analytical interpretations, not declared eligibility rules, investment advice, or statements about current investment appetite.

  • A founder or management recapitalization: An established service business seeking a majority capital partner while preserving management participation resembles the partnership model evident in Capstone and other NMS transactions.
  • A fragmented service market with platform potential: A business that can combine complementary operators and invest in shared infrastructure resembles the approach documented at Flourish Research. Fragmentation alone, however, does not establish investment suitability.
  • A specialized equipment-services opportunity: A company with repair expertise, technical capabilities, or equipment-lifecycle services is consistent with the investment relationships involving DirectMed, Surplus Solutions, and Asurgence.
  • A platform requiring organizational development: A profitable company that needs additional management resources, better information systems, or support for acquisitions is consistent with NMS’s disclosed operating-support model.

Any individual situation would still need to be assessed against the firm’s sector mandate, geography, operating characteristics, and transaction economics. The examples do not establish that NMS is currently pursuing a particular company or that a business would qualify for an investment.

12. What Distinguishes NMS Capital?

Several characteristics help explain NMS’s investment proposition without implying superiority over other investors.

  • A defined services orientation: The current firm centers on business and industrial services and healthcare services. Its portfolio includes both direct healthcare delivery models and companies supplying specialized services to healthcare, industrial, and commercial customers.
  • Growth within a control-investment model: NMS combines majority ownership with management participation and strategic board-level involvement. Its growth language should not be confused with an exclusively minority growth-equity strategy.
  • Explicit restraint on financial engineering: The firm’s investment principles emphasize people, growth, and strategic decisions while cautioning against using all available debt. This is a stated investment philosophy, not a verified leverage statistic for the portfolio.
  • Internal and external operating resources: A dedicated Portfolio Optimization Group sits alongside an industry executive network. The combination separates ongoing portfolio support from sector experience used in sourcing and investment development.
  • Institutional development alongside fund succession: Successive funds have been accompanied by organizational changes, including the dedicated business-development leadership position established in June 2026. This describes the firm’s development, not evidence of superior fundraising or investment results.

13. How Should NMS Capital Be Understood Today?

As reviewed on October 13, 2026, NMS is best understood as a co-founder-led, services-focused private equity firm with a majority-investment model. Its central geographic mandate concerns platforms headquartered in the United States and Canada. The current focus is more specifically services-oriented than the broader consumer-inclusive remit described in its early Fund II announcement.

Recent development includes Fund V’s identifiable offering, the establishment of dedicated business-development leadership, and the addition of Asurgence Medical. In its June 15, 2026 announcement, NMS reported reaching a US$2 billion assets-under-management milestone. The announcement did not separately identify an underlying valuation date, so that figure should not be presented as an October 13 ownership or financial measurement.

Transaction status also matters. Strive Medical’s July sale agreement was followed by a completed acquisition, which supports its Former classification. Other selected businesses remain supported by affirmative current-portfolio evidence. The firm’s website can contain both historical and current investments, so appearance on a general portfolio page alone is not sufficient to determine ownership.

The important limitations are specific: Fund V’s final-close total is not verified, several company-level fund allocations remain unverified, and the portfolio table is selective. Directory inclusion describes the researched organization and investment model, not investment performance, current appetite, or suitability for a particular business.

14. Frequently Asked Questions

Who founded NMS Capital?

Martin E. Chavez and Kevin M. Jordan founded NMS in 2010 following a spin-out of investments from Goldman Sachs’ Merchant Banking Division. Both remain identified by the firm as co-founders and managing partners.

Is NMS Capital a buyout firm or a growth-equity firm?

NMS’s disclosed model is growth-oriented majority investing. Control buyouts are therefore the closer directory classification. Growth is an operating objective within that model, rather than evidence that NMS primarily makes minority growth-equity investments.

Which sectors are most important to NMS Capital?

The firm’s two principal areas are business and industrial services and healthcare services. Documented examples include commercial maintenance, environmental services, IT consulting, medical communications, clinical research services, and specialized equipment support.

Where is NMS Capital based, and where does it invest?

NMS is headquartered in New York and also maintains a Dallas office. Its current platform-company mandate covers the United States and Canada. Portfolio-company customer coverage and international expansion can extend beyond that headquarters-based investment criterion.

What is the latest NMS fund verified in this profile?

NMS Fund V is the latest numbered fund verified. Its April 2026 amended offering notice establishes an ongoing fund offering and cumulative interests sold. It does not establish a final-close amount across all potentially related investment vehicles.

Is Strive Medical still an NMS Capital portfolio company?

Strive is classified as Former. Although NMS initially announced a sale agreement, Cardinal Health’s subsequent disclosure confirms that its acquisition was completed in July 2026. The completed transaction supersedes the earlier agreement-stage ownership information.

What operating support does NMS Capital provide?

NMS identifies an internal Portfolio Optimization Group, an Operating Executive Council, talent support, acquisition assistance, and data-related resources. These are disclosed capabilities; their existence does not establish identical deployment or achieved outcomes at every portfolio company.